REG - AIM Beximco Pharma. - Restoration - Beximco Pharmaceuticals Limited

Beximco PharmaceuticalsAnnouncement

12/11/2024 10:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241112:nRSL9070La&default-theme=true

RNS Number : 9070L  AIM  12 November 2024

NOTICE

 

12/11/2024 10:00am

 

RESTORATION OF TRADING ON AIM

 

BEXIMCO PHARMACEUTICALS LIMITED

 

Trading on AIM for the under mentioned securities was temporarily suspended.
The suspension is lifted from 12/11/2024 10:00am, an announcement having been
made.

 

GLOBAL DEPOSITARY RECEIPTS (EACH REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH),
FULLY PAID

(B0DM5S5) (US0885792061)

 

If you have any queries relating to the above, please contact the Company's
nominated adviser on +44 (0) 20 3368 3551.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  EXCGPGBCGUPCUBP